NCT05394623 Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study) Status UNKNOWN Phase N/A
NCT05382299 Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05382286 Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05378399 SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder Status COMPLETED Phase PHASE3
NCT05370053 The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology Status COMPLETED Phase NA
NCT05369507 Eliminating HCV in Rural South Carolina Utilizing NP Led Mobile Clinics and Virtual Care Coordination Status COMPLETED Phase NA
NCT05330429 Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC) Status TERMINATED Phase PHASE2
NCT05329766 A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05281510 Study of VRC07-523LS, CAP256V2LS, and Vesatolimod, in Early Antiretroviral-treated HIV-1 Clade C-infected Women Status COMPLETED Phase PHASE2
NCT05277012 A Study to Evaluate Pharmacokinetics (PK) of Etrumadenant Tablet and Capsule Formulations in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT05222945 A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide Status NOT_YET_RECRUITING Phase NA
NCT05186974 Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05177926 Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF) Status UNKNOWN Phase PHASE4
NCT05175339 Long-term Impact in Intensive Care Survivors of Coronavirus Disease (COVID-19) Status COMPLETED Phase N/A
NCT05169944 Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors Status COMPLETED Phase PHASE1